1-9 of 9
John Reneau
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated clinical data and biomarker analyses from the phase 1 study of DR-01, a non-fucosylated anti-CD94 antibody in patients with relapsed/refractory cytotoxic lymphomas

Free
Steven Horwitz, Jasmine Zain, Christiane Querfeld, Youn-H Kim, Michael Khodadoust, Tarek Bandali, Won Seog Kim, Christina Poh, Costas Yannakou, John Reneau, Jonathan Brammer, Cinzia Pellegrini, Pier Luigi Zinzani, Oleg Akilov, Enrica Marchi, Yok-Lam Kwong, Ji Hyun Lee, Youngil Koh, Jenna Reed, Kimberley Dilley, Wan-Jen Hong, Ruoshi Shi, Jennifer Richardson, Nenad Tomasevic, H. Miles Prince, Swami Iyer
Journal: Blood
Blood (2025) 146 (Supplement 1): 3646.
https://doi.org/10.1182/blood-2025-3646
Published: 2025
Journal Articles

Phase ib study to assess the efficacy and safety of epcoritamab in relapsed or refractory post-transplant lymphoproliferative disorder

Free
Timothy Voorhees, Rina Welkie, Hemalatha Rao, Yazeed Sawalha, David Bond, Audrey Sigmund, Yun Choi, John Reneau, Walter Hanel, Polina Shindiapina, Jonathan Brammer, Beth Christian, Lapo Alinari, Nancy Bartlett, Kami Maddocks, Robert Baiocchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 8240.
https://doi.org/10.1182/blood-2025-8240
Published: 2025
Journal Articles

Phase IB/II trial of epcoritamab plus ibrutinib in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

Free
Yazeed Sawalha, Marie Hu, Rina Welkie, Aubree Shoemaker, Yun Choi, Audrey Sigmund, Timothy Voorhees, David Bond, John Reneau, Lapo Alinari, Jonathan Brammer, Beth Christian, Robert Baiocchi, Veronika Bachanova, Kami Maddocks
Journal: Blood
Blood (2025) 146 (Supplement 1): 8239.
https://doi.org/10.1182/blood-2025-8239
Published: 2025
Journal Articles

Final results of a phase 1 trial with soquelitinib (SQL), a selective interleukin-2-inducible T cell kinase (ITK) inhibitor for treatment of relapsed/refractory (R/R) T cell lymphomas (TCL)

Free
Richard Miller, Ryan Wilcox, John Reneau, Costas Yannakou, Won Seog Kim, Tatyana Feldman, Youn-H Kim, Michael Khodadoust, Dejan Radeski, Robin Gasiorowski, Dok Hyun Yoon, Yuqin Song, Andrew Hotson, Suresh Mahabhashyam
Journal: Blood
Blood (2025) 146 (Supplement 1): 778.
https://doi.org/10.1182/blood-2025-778
Published: 2025
Journal Articles

Targeting the methylome in T-LGL leukemia: Pre-clinical analysis and Results of a Phase I trial with oral 5-azacytidine

Free
Jonathan Brammer, Zachary Braunstein, Patrick Stevens, Zachary Hutchins, Giulia Calabretto, Soprina Guarneri, Eric McLaughlin, Amy Boles, John Reneau, Walter Hanel, Enrica Marchi, Maciej Pietrzak, Anjali Mishra
Journal: Blood
Blood (2025) 146 (Supplement 1): 890.
https://doi.org/10.1182/blood-2025-890
Published: 2025
Journal Articles

PRMT5 is a therapeutic vulnerability in cutaneous T-cell lymphoma

Free
Nicole Peterman, Pushpa Lata, Christoph Weigel, Sydney Leon, Ian Hout, Wing Chan, Ronny Schmidt, Ha Tran, Youssef Youssef, Peggy Scherle, Neha Bhagwat, John Reneau, Catherine Chung, Jonathan Brammer, Ryan Wilcox, Lapo Alinari, Robert Baiocchi, Walter Hanel
Journal: Blood
Blood (2025) 146 (Supplement 1): 1529.
https://doi.org/10.1182/blood-2025-1529
Published: 2025
Journal Articles

Safety and immunomodulatory effects of siltuximab prophylaxis prior to standard of care CD19 directed chimeric antigen receptor T-cell (CD19.CART) therapy for B-cell lymphomas: Final phase I trial results

Free
Nathan Denlinger, NoJoon Song, Negin Goodarzi, Rina Welkie, Jungmin Shin, Jordan Krull, Kathleen McConnell, Narendranath Epperla, Jonathan Brammer, Yazeed Sawalha, David Bond, Evandro Bezerra, John Reneau, Audrey Sigmund, Yun Choi, Walter Hanel, Lapo Alinari, Polina Shindiapina, Gabriela Sanchez-Petitto, Hannah Choe, Sarah Wall, Jiasheng Weng, Chelsea Steiner, Xiaopei Huang, Beth Christian, Sam Penza, Robert Baiocchi, Kami Maddocks, Samantha Jaglowski, Sumithira Vasu, Qin Ma, Dongjun Chung, Mark P Rubinstein, Zihai Li, Marcos de Lima, Paolo Caimi, Timothy Voorhees
Journal: Blood
Blood (2025) 146 (Supplement 1): 2385.
https://doi.org/10.1182/blood-2025-2385
Published: 2025
Journal Articles

Anti-CD19 chimeric antigen receptor T-cell therapy for patients with non-Hodgkin's lymphoma and concurrent autoimmune disease

Free
Zachary Braunstein, Eric McLaughlin, Timothy Voorhees, Jiasheng Wang, Evandro Bezerra, David Bond, Audrey Sigmund, Robert Baiocchi, Yun Choi, John Reneau, Yazeed Sawalha, Kami Maddocks, Walter Hanel, Lapo Alinari, Beth Christian, Kerry Rogers, Seema Bhat, Jisna Paul, Ali Ajam, Judith Lin, Gabriela Sanchez-Petitto, Polina Shindiapina, Sarah Wall, Jennifer Woyach, Wael Jarjour, Sumithira Vasu, Marcos de Lima, Jonathan Brammer, Alexa Meara, Nathan Denlinger
Journal: Blood
Blood (2025) 146 (Supplement 1): 1935.
https://doi.org/10.1182/blood-2025-1935
Published: 2025
Journal Articles

Cardiotoxicity Risk with Bortezomib Versus Lenalidomide for Treatment of Multiple Myeloma: A Propensity-Matched Study of 1,128 Patients

Free
John Reneau, MD PhD, Dennis Asante, MS, Holly Van Houten, BA, Francis Buadi, MD, Amir Lerman, MD, Joerg Herrmann, MD
Journal: Blood
Blood (2015) 126 (23): 3046.
https://doi.org/10.1182/blood.V126.23.3046.3046
Published: 2015